CORTRAK 2 NASOGASTRIC/NASOINTESTINAL FEEDING TUBE WITH ELECTROMAGNETIC TRANSMIT
Report
- Report Number
- 9611594-2019-00147
- Event Type
- Malfunction
- Date Received
- August 2, 2019
- Date of Event
- July 11, 2019
- Report Date
- October 3, 2019
- Manufacturer
- AVANOS MEDICAL INC.
- Product Code
- KNT
- PMA / PMN Number
- K821906
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- WI, US
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
Narratives
THE ACTUAL COMPLAINT PRODUCT WAS RETURNED FOR EVALUATION. ONE USED SAMPLE WAS RECEIVED WITHOUT PRODUCT PACKAGING; THE PRODUCT DOES NOT CONTAIN A LOT NUMBER IDENTIFICATION. THE TUBING EXHIBITS "BALLOONING" WITH COMPLETE RUPTURE AT THE 33CM MARK. BOTH SEGMENTS WERE FOUND TO BE COMPLETELY OCCLUDED WITH DRIED MATTER. THE ROOT CAUSE OF THE REPORTED ISSUE COULD NOT BE DETERMINED. HOWEVER, A POTENTIAL CAUSE IS USE ERROR AS PER THE INSTRUCTIONS FOR USE, VIGOROUS SYRINGE FORCE SHOULD NOT BE USED TO IRRIGATE, ADMINISTER LIQUIDS, OR UNBLOCK THE TUBE. ALL INFORMATION REASONABLY KNOWN AS OF 02 OCT 2019 HAS BEEN INCLUDED IN THIS HEALTH AUTHORITY REPORT. SHOULD ADDITIONAL INFORMATION BE OBTAINED, A FOLLOW-UP HEALTH AUTHORITY REPORT WILL BE PROVIDED. THE INFORMATION PROVIDED BY AVANOS MEDICAL INC. REPRESENTS ALL OF THE KNOWN INFORMATION AT THIS TIME. DESPITE GOOD FAITH EFFORTS TO OBTAIN ADDITIONAL INFORMATION, THE COMPLAINANT / REPORTER WAS UNABLE OR UNWILLING TO PROVIDE ANY FURTHER PATIENT, PRODUCT, OR PROCEDURAL DETAILS TO AVANOS MEDICAL INC. AVANOS MEDICAL INC. HAS NO INDEPENDENT KNOWLEDGE OF THE EVENT REPORTED BUT IS RELAYING THE INFORMATION THAT WAS PROVIDED BY THE USER FACILITY WHERE THE INCIDENT OCCURRED. THIS PRODUCT INCIDENT IS DOCUMENTED IN THE HALYARD HEALTH COMPLAINT DATABASE AND IDENTIFIED AS COMPLAINT (B)(4). THIS INFORMATION IS SUBMITTED PURSUANT TO 21CFR803, IN COMPLIANCE WITH THE MEDICAL DEVICE REPORTING REQUIREMENT AND SHOULD NOT BE CONSIDERED TO BE AN ADMISSION THAT AN AVANOS MEDICAL INC. PRODUCT IS DEFECTIVE OR CAUSED SERIOUS INJURY.
THE PRODUCT INVOLVED IN THE REPORT HAS BEEN RETURNED AND IS BEING PROCESSED FOR EVALUATION. A REVIEW OF THE DEVICE HISTORY RECORD IS NOT POSSIBLE AS NO LOT NUMBER WAS PROVIDED. ALL INFORMATION REASONABLY KNOWN AS OF 02 AUG 2019 HAS BEEN INCLUDED IN THIS HEALTH AUTHORITY REPORT. SHOULD ADDITIONAL INFORMATION BE OBTAINED, A FOLLOW-UP HEALTH AUTHORITY REPORT WILL BE PROVIDED. THE INFORMATION PROVIDED BY AVANOS MEDICAL INC. REPRESENTS ALL OF THE KNOWN INFORMATION AT THIS TIME. AVANOS MEDICAL INC. HAS NO INDEPENDENT KNOWLEDGE OF THE EVENT REPORTED BUT IS RELAYING THE INFORMATION THAT WAS PROVIDED BY THE USER FACILITY WHERE THE INCIDENT OCCURRED. THIS PRODUCT INCIDENT IS DOCUMENTED IN THE HALYARD HEALTH COMPLAINT DATABASE AND IDENTIFIED AS COMPLAINT (B)(4).
IT WAS REPORTED THAT A NG [NASOGASTRIC] TUBE HAD "A HOLE IN IT." THE ISSUE WAS NOTICED DURING A KUB [KIDNEY-URINARY-BLADDER X-RAY]." NO PATIENT INJURY WAS REPORTED. ADDITIONAL INFORMATION RECEIVED ON 29-JUL-2019 INDICATED THE "TUBE DID NOT BREAK INTO TWO PIECES, ALTHOUGH IT IS HANGING BY A 'THREAD,' APPEARS IT BALLOONED OUT & BURST...TUBE REMOVED MANUALLY." DEVICE WAS PLACED ON (B)(6) 2019 AT 2121 AND WAS REMOVED ON (B)(6) 2019. THE PACKAGING WAS NOT SAVED. THE DEVICE WAS NOT REPROCESSED OR REUSED. "NO PROBLEMS WITH DEVICE, ISSUE WAS FOUND INCIDENTALLY VIA XRAY. PATIENT WAS GETTING AN XRAY TO ASSESS STOOL BURDEN...PATIENT RECEIVING CONTINUOUS TUBE FEED VIA DHT [DOBHOFF TUBE] AT 120ML/HR. NO ISSUES IDENTIFIED WITH FLUSHING OR ROUTINE USE OF DHT." NO OTHER DEVICES OR THERAPIES WERE BEING USED ON THE PATIENT AT THE TIME OF THE EVENT THAT MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT. PATIENT STATUS WAS REPORTED AS "NO ILL EFFECTS THAT WE KNOW OF, DISCHARGED."
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 649103 | CORTRAK 2 NASOGASTRIC/NASOINTESTINAL FEEDING TUBE WITH ELECTROMAGNETIC TRANSMIT | DH CORTRAK DISPOSABLES | KNT | AVANOS MEDICAL INC. | 40-9551TRAK2 | UNKNOWN |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 38 YR |